ScholarWorks@Dongguk University: Lee, Kyeong

Detailed Information

Lee, Kyeong (이경)

College of Pharmacy (Department of Pharmacy)

Research Area

Tel 031-961-5214
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

LW6:5||kinase inhibitors:5||RhoB:5||bioavailability:4||synthesis:4||PC12 cells:4||Drug discovery:4||NSC126188:4||Pglycoprotein:4||molecular docking:4||(R)TEMOSPho:3||oxidative stress:3||Asthma:3||Molecular docking:3||Apoptosis:3||molecular modelling:3||Neuroprotection:3||HCV replication inhibitors:2||kinase panel:2||anticancer:2||Fibroblastlike synoviocytes:2||Structureactivity relationship (SAR) study:2||Structurebased virtual screening (SBVS):2||Parkinson's disease:2||Synthesis:2||MAOB:2||apoptosis:2||Chemical genetics:2||Perifosine:2||spectroscopic characterization:2||Target identification:2||docetaxel:2||Free energy calculations:2||structureactivity relationship:2||structureactivity relationship (SAR):2||Platelet:2||drug repurposing:2||drug resistance:2||EGFR:2||topotecan:2||Akt:2||bioactive molecules:2||Breast cancer:2||HIF1 inhibitors:2||LC478:2||Carbonic anhydrase inhibitors:2||molecular modeling:2||Megakaryocyte:2||Epithelialmesenchymal transition:2||Norovirus:2||LMT28:2||DDR1 inhibitors:2||absorption:2||Indole derivatives:2||STAT3:2||Molecular dynamics:2||Molecular dynamics (MD) simulation:2||pharmacokinetics:2||Collageninduced arthritis:2||Inflammation:2||Monoamine oxidase B:2||Angiogenesis:2||Hepatitis C virus:2||inhibitors:2||Paclitaxel:2||Cerebral ischemia:1||Charged aerosol detector:1||Chemical biology:1||Chemotaxis:1||Ciclopirox:1||Ciliopathy, Sonic hedgehog:1||Citrus:1||Cleft palate:1||Continuous manufacturing:1||Coumarin derivative:1||Cudraisoflavone J:1||Cytokines:1||DAPK1:1||DAPK1 inhibitors:1||DDR1 and DDR2:1||DGAT:1||DGAT inhibitor:1||DK1108:1||DPPH:1||Daunomycin:1||Design of experiment:1||Diacylglycerol Oacyltransferase:1||Diacylglycerol Oacyltransferase inhibitor:1||Difluoromethoxy group:1||Discovery:1||Drug design:1||Drug development:1||Drug repurposing:1||EPharmacophore modeling:1||Epharmacophore modeling:1||EMP2:1||Enamines:1||Endocrinecerebroosteodysplasia (ECO) syndrome:1||EphB3:1||Ethacrynic acid:1||FDAapproved drugs:1||FMS:1||FRAP:1||Fat browning:1||FoxO3a:1||Fragmentbased drug design:1||Fructose1,6bisphosphatase inhibitors:1||Functionalized nucleosides:1||GISTs:1||GTPase RAt Sarcoma (Ras):1||GTPase rat sarcoma (Ras):1||Gli:1||Gymnasterkoreayne B:1||Gymnasterkoreayne E:1||H2O2:1||HCV genome replication:1||HCV particle production:1||HER2:1||HER2:1||HER2 dual inhibition:1||HIF inhibitors:1||HIF1 alpha:1||HIF1 alpha inhibitor:1||HIF1 alpha inhibitors:1||HIF1α:1||HIF1α inhibition:1||HSF1:1||Hantzschtype onepot approach:1||Heat shock factor1:1||Hedgehog pathway:1||Hedgehog signaling pathway:1||Heme oxygenase1:1||Hepatitis C virus (HCV):1||Histone phosphorylation:1||Homoegonol:1||Hydrazide:1||Hypoxia:1||Hypoxiainducible factor1 alpha:1||ICAM1:1||IDF11774:1||II inhibitors:1||IL6 antagonists:1||IL6 inhibitors:1||IL6 signaling inhibitor:1||Immunotherapy:1||Indole basedbenzenesulfonamide:1||Inducible nitric oxide synthase:1||Inflammatory airway disease:1||Inhibition of melanoma growth and metastasis:1||Inhibitor:1||Inhibitors:1||Isocitrate dehydrogenase1 ( IDH1):1||Isoindolinone:1||JNK inhibitor:1||K562:1||KEAP1:1||KELCHlike ECHassociated protein 1 (KEAP1):1||Key Words:1||Kornblum oxidation:1||LCK:1||LDL:1||LDLR:1||LW1497:1||LYN:1||Lck inhibitors:1||Leukotriene B4 receptor 2:1||Leukotriene B4 (LTB4):1||Leukotriene B4 receptor 2 (BLT2):1||Lindlar catalyst:1||Lipid nanoparticles:1||Liver cancer:1||Lun cancer:1||MAOA:1||MAOB inhibitor:1||MAOB inhibitors:1||MAPK:1||MDH1/2:1||MMGBSA:1||MMGBSA calculations:1||MMGBSA study:1||MYC:1||Machine learning:1||Matrix metalloproteinase9:1||Melanogenesis:1||Melanoma:1||Melanosome transfer:1||Metformin:1||Microfluidic device:1||Molecular hybridisation:1||Monoamine oxidase:1||Moracins:1||Mulberries:1||Multiinput neural network:1||Multidrug resistance:1||Nhydroxypyridone:1||Nphenacyl pyrrole2carbonitriles:1||NFE2related factor 2 (NRF2):1||NRF2:1||NS5B RNA polymerase inhibitor:1||Naphthalenebased derivatives:1||Naphthamide:1||Naphthoquinones:1||Naringin:1||Natureinspired chiralfree benzofuran:1||Negative regulator:1||Neurological:1||Nifuroxazide:1||Nonnucleoside:1||Novel discoidin domain receptor 1 (DDR1):1||Nuclear factor erythroid 2related factor 2:1||ORAC:1||Obesity:1||Openring form of aliphatic amidoquaternary ammonium salts:1||Oral bioavailability:1||Osteoclastogenesis:1||Oxazolidinone:1||Oxidative stress:1||Pgp and BCRP dual inhibition:1||PARP1:1||PCSK9:1||PQLC2:1||PRR16:1||PanRaf kinase inhibitors:1||Parkinson ?s disease:1||Parkinson's disease (PD):1||Patientderived cancer organoid:1||Penfluridol:1||Pharmaceutical application:1||Phytosphingosine:1||Polyacetylene:1||Prostate cancer:1||Quinazoline:1||Quinazolinebenzenesulfonamide hybrids:1||Quinazolinone:1||RNA replication inhibitor:1||RNAbinding protein:1||ROS:1||Regiospecific epoxide opening:1||Repurposing:1||Reversible inhibitors:1||Rheumatoid arthritis:1||SAR:1||SARSCov2 Mpro:1||SCFR:1||SREBP1:1||Safety:1||Scaffold hopping:1||Secondary indication:1||Selectivity:1||Selfvalidated ensemble model:1||Shikonininduced apoptosis:1||Siah1:1||Smo:1||Smoothened:1||Smoothened agonist (SAG):1||Src family kinase:1||Stilbenoid analogs:1||Structure–activity relationship (SAR):1||Structure hopping:1||Suzuki coupling:1||T helper 17:1||TRP1:1||TRP2:1||TYR:1||Tetrahydropapaverine:1||Th17:1||Th2 cytokines:1||Thrombopoietin:1||Triglyceride:1||Triglycerides:1||Tumour microenvironment:1||Tumour regression:1||UCP1:1||Ubiquitinspecific protease 21 (USP21):1||VLDL:1||Vaccine manufacturing:1||Verapamil:1||Verbenone:1||Vinylstilbene:1||Vinylstilbenes:1||Virtual screening:1||XGBoost:1||Xenograft:1||activity relationship:1||adenosine 5 'monophosphate:1||aldol condensation:1||allosteric modulation:1||alphaKetoglutarate (alphaKG):1||alphaMangostin:1||and molecular docking:1||angiogenesis:1||antiHIV:1||antiangiogenics:1||antibacterial activity:1||anticancer:1||antiproliferative:1||antiproliferative activity:1||antibiotics:1||anticancer activity:1||anticancer agents:1||anticancer effect:1||antimigration:1||antioxidant activity:1||antiproliferative activity:1||antiresorptive drugs:1||aryl boronic acids:1||aryl carboxamides:1||asymmetric synthesis:1||autophagy:1||azelastine:1||azepane scaffold:1||bacterial infections:1||benzoxazoles:1||biologically active nucleosides:1||bone destruction:1||brain health:1||breast cancer:1||cAbl:1||cJun:1||cJun Nterminal kinase:1||cKIT:1||cKIT inhibitors:1||ckit inhibitors:1||caffeic acid:1||cancer:1||cancer metabolism:1||cancerrelated pain:1||cantharidin:1||carbopalladation:1||carbonic anhydrase inhibitor:1||carbonic anhydrase inhibitors:1||carboxamide:1||cell senescence:1||chalconebased benzenesulfonamides:1||chemical study:1||chemical synthesis:1||chemotherapeutics:1||chemotype:1||chronic disease:1||click chemistry:1||combination therapy:1||competitive inhibitors:1||cyclic ethers:1||cyclin B:1||cytotoxicity:1||deathassociated protein kinase 1 (DAPK1):1||deubiquitinase (DUB):1||diabetes mellitus:1||diacylglycerol acyltransferase:1||diacylglycerol acyltransferase (DGAT):1||diamondback moth:1||dioxolane nucleosides:1||discoidin domain receptor (DDR):1||dissolution:1||divergent synthesis:1||dopamine:1||doxorubicin:1||drug discovery:1||dual Topo I:1||dualtarget inhibition:1||epithelialmesenchymal transition:1||excipient:1||fibroblast:1||fluorescent probes:1||fluorinated nucleosides:1||gastric cancer:1||gp130:1||hepatitis C virus:1||hepatitis C virus (HCV):1||heterocycles:1||heterocyclic:1||histone deacetylases:1||hnRNPA2B1:1||homoegonol:1||hormone modulators:1||hybrid triple quadrupolelinear ion trap mass spectrometer:1||hybridization strategy:1||hyperglycemia:1||hypoxia:1||hypoxia inducible factoralpha 1:1||hypoxiainducible factor1 (HIF1):1||hypoxiainducible factor1&#945:1||hypoxic cancer:1||in silico docking simulation:1||in silico pharmacokinetics:1||indole:1||indole derivatives:1||indolebased benzenesulfonamide:1||inflammatory disease:1||inhibition:1||insecticide:1||kinase assay:1||lapatinib:1||leucettine:1||ligand efficacy:1||lipid droplet (LD):1||liquid chromatographytandem mass spectrometry:1||liver microsomes:1||local oxygen tension:1||lung adenocarcinoma (LUAD):1||lung cancer:1||lymphocytespecific protein tyrosine kinase (Lck):1||malate dehydrogenase:1||malate dehydrogenase2:1||marineinspired kinase inhibitors:1||medicinal chemistry:1||medulloblastoma:1||melatonin:1||meridianins:1||metabolic disorders:1||metabolism:1||metabolite identification:1||metastasis:1||miR1299:1||miR4458:1||mice pharmacokinetics:1||microwave synthesis:1||modified nucleosides:1||molecular dynamics:1||monoamine oxidase B:1||mutagenesis study:1||natural products:1||neurodegeneration:1||neuroinflammation:1||neuroprotection:1||nitro group containing drugs:1||nuclear factorkappa B (NFkappa B):1||oral bioavailability:1||osteoclast:1||osteoclast maturation:1||p21(Cip1):1||p300:1||p38 MAPK:1||pd(TFA)(2):1||photoaffinity labeling:1||phototherapeutic agents:1||predictive multiple reaction monitoringinformation dependent acquisitionenhanced product ion:1||proinflammatory cytokines:1||prostate carcinoma:1||pyridineurea:1||pyrimidine:1||pyrrolo[1,2alpha]pyrazines:1||quinazoline sulfonamide:1||rat plasma:1||repeated treatment:1||replication inhibitors:1||rotenone:1||saturated oxygen heterocycles:1||selectivity profile:1||selenium nanoparticles:1||selenonucleosides:1||selfnanoemulsifying drug delivery system:1||slug:1||small molecule:1||small molecules:1||smallmolecule inhibitors:1||solid dispersion:1||solubilization:1||steatosis:1||stem cell growth factor:1||structure activity relationships:1||structure&#8211:1||structurebased virtual screening:1||targeted cancer therapy:1||therapeutic target:1||thionucleosides:1||total synthesis:1||transcriptional activation:1||triacylglycerides:1||tubulin inhibitors:1||tumor formation:1||tumor growth:1||tumor hypoxia:1||tumor microenvironment:1||type 2 diabetes:1||ubiquitination:1||verbenone:1||virtual combinatorial library:1||(+/)Nyasol:1||vismodegib:1||(Nrf2):1||(R)2Hydroxyglutarate (R2HG):1||1433 epsilon:1||3D QSAR:1||4 'ObetaDGlucosyl5Omethylvisamminol:1||4 'acetylene nucleosides:1||4Aminopyrroles:1||4Anilinoquinoline:1||6hydroxydopamine:1||A549:1||ABI2:1||ABL1 kinase:1||ABTS:1||AC1497:1||ACAT inhibitors:1||ADME studies:1||AIDS:1||AIMP2DX2:1||AMPactivated protein kinase (AMPK):1||AMPK:1||AMPK signaling pathway:1||ANLN:1||ARG2:1||ARL1:1||ASK1:1||ATP citrate lyase (ACLY):1||ATPase activity:1||Adamantyl derivatives:1||Aliphatic amidoquaternary ammonium salts:1||Aliphatic amido/sulfonamidoquaternary ammonium salts:1||Amide coupling:1||Analytical quality by design:1||Anticancer:1||Antiexcitotoxic activity:1||Antiischemic activity:1||Antioxidant activity:1||Anticancer:1||Anticancer agents:1||Anticancer drug:1||Antiviral mechanism of action:1||Approved drugs:1||Artificial intelligence:1||Aster koraiensis:1||Astrocytes:1||Aurora B kinase:1||Aurora Kinase A and B:1||B7H4:1||BCRP:1||BCRP inhibitor:1||BLT2 antagonist:1||BRCA1associated protein 1 (BAP1):1||BV2 microglial cells:1||Bayesian optimization:1||Benzamide:1||Benzofuran:1||Bioavailability:1||Biological activity:1||CADD:1||CDK1:1||CXCL8:1||Caco2 cells:1||Calcineurin b homologous protein 1:1||Cancer:1||Cellular cholesterol:1||

RSS_1.0 RSS_2.0 ATOM_1.0

30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE